Int. J. Radiat. Oncol. Biol. Phys. 2011 Jun 15
Esthesioneuroblastoma: is there a need for elective neck treatment?
Abstract
Purpose
To assess the risk of cervical lymph node metastases after definitive treatment for esthesioneuroblastoma (ENB) that did not include elective neck therapy.
Methods and materials
This was a retrospective analysis of 26 ENB patients treated at the University of Michigan between 1995 and 2007. Tumor stage was Kadish A in 1 patient, B in 19, C in 5, and unknown in 1. Craniofacial or subcranial resection was performed in 24 patients (92%), with negative margins in 22 (92%). Postoperative radiotherapy (RT) to the primary site was given in 12 patients (46%), and 14 patients (54%) had surgery alone. All patients had clinically N0 disease, and no patient underwent elective neck dissection or radiation. Median follow-up was 72 months.
Results
Local relapse-free survival was significantly better for patients who received postoperative RT compared with those who had surgery alone: 100% vs. 29% at 5 years, respectively (p = 0.005). Five-year disease-free survival was 87.5% in the RT group vs. 31% in the surgery-alone group (p = 0.05). Regional failure was observed in 7 patients (27%), 6 with Kadish Stage B and 1 with Stage C disease. The most common site of nodal failure was Level II, and 3 patients failed in the contralateral neck. Only 3 patients with regional failure were successfully salvaged.
Conclusion
The high rate of regional failures when the neck is not electively treated justifies elective nodal RT in patients with both Kadish Stages B and C. In addition, our experience confirms the beneficial effect on local control of adjuvant RT to the tumor bed.
Related Questions
What is your experience and practice patterns when treating midline NUT carcinoma of the head and neck?
Of the neuroendocrine HN cancers, NUT cancers are very rare undifferentiated or poorly differentiated squamous cell carcinoma defined by rearrangement of the NUTM1 (aka NUT) gene. Due to the rarity of this disease, published reviews include mostly assortments of case reports with conflicting results...
Are there any circumstances in which you would recommend adjuvant chemoradiation for resected olfactory neuroblastoma?
Agree with Dr. @Dr. First Last. Our experience treating 29 patients with Kadish B and C neuro esthesioneuroblastoma with local RT if positive margins, and no neck RT when the neck was N0, resulted in 27% neck failure including in the contralateral neck. 5-year LRF rate was 29% in patients who did no...
In what situations do you treat the elective neck for patients with resected esthesioneuroblastomas?
Our experience (Demiroz C et al., IJROBP 2011) includes 26 patients with ENB, all of whom had N0 neck at diagnosis, and none had received neck RT (about half received primary site adjuvant RT). The results were: 26% neck recurrences: 6/19 in Kadish B and 1/5 in Kadish C. Most recurrences were in lev...